Your browser does not support Javascript
Multiple Sclerosis Association of America Logo
Link to FaceBook Link to Twitter Link to YouTube Link to Pinterest
Register Why Register Contact MSAA Site Preferences Print Page Home
Improving Lives Today!
Donate Button
Manage Your MS
My MS Journey
MSAA's Shared-Management Tools
S.E.A.R.C.H.™ for Treatment Options
My MS Manager™ (Mobile App)
My MS Resource Locator®
MS Relapse Resource Center
Overall Wellness
MSi Online Videos
MSAA Publications

Home > Manage Your MS > MSi Online Videos > A Closer Look at Gilenya - The First Oral Treatment for MS
Share this Page:
submit to reddit
This optional registration will enable us to notify you when additional programming becomes available. All fields are required. If you've previously signed up for email updates with MSAA, simply select "Skip Registration" to continue to the video.

* Email Address
* First Name
* Last Name
* Zip Code
* Anti-Spam Please click this option for security purposes

By clicking submit, you are agreeing to the terms and conditions outlined in the MSAA privacy policy.
Skip Registration

A Closer Look at Gilenya - The First Oral Treatment for MS

MSAA's Chief Medical Officer Dr. Jack Burks answers 6 important questions about Gilenya, the new oral medication for MS, including:

  • what is Gilenya
  • how it differs from current FDA-approved disease modifying therapies?
  • side effects
  • who might be a candidate to take it
  • pregnancy issues
Last Updated on Thursday, 20 November 2014 14:30